Avanir Pharmaceuticals

About:

Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.

Website: http://www.avanir.com

Twitter/X: avanirpharma

Top Investors: OrbiMed, Silicon Valley Bank, Oxford Finance LLC, Jennison Associates

Description:

Avanir Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of their commitment, they have extensively invested in their pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones.

Total Funding Amount:

$46.2M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Aliso Viejo, California, United States

Founded Date:

1988-01-01

Contact Email:

bizdev(AT)avanir.com

Founders:

David H. Katz

Number of Employees:

101-250

Last Funding Date:

2012-06-26

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai